The pilot results provide validation for SenesTech's municipal sales strategy, but the press release contains no new financial data. Monitor the full Q3 2026 earnings release expected the week of November 9, 2026, for revenue, gross margin, and cash burn details that will determine if the commercial momentum is translating into improved unit economics.
Price Chart
Executive Summary
SenesTech announced results from a Chicago pilot showing an 88% reduction in rat activity intensity using Evolve Rat Birth Control, with expansion to six Chicago-area SSAs and wards. The press release follows a preliminary Q3 2026 revenue pre-announcement of ~$1.1M (record high, +55% YoY), but the filing is a product update, not an earnings report, and contains no new financial data beyond the previously disclosed preliminary revenue figure.
Key Facts
- Pilot in Chicago's Wicker Park Bucktown SSA #33 showed 88% reduction in average rat activity intensity and 82% reduction in monitoring locations with detectable activity over 12 months.
- Rodent-related 311 calls in the deployment area fell 36% (158 to 101) while citywide calls increased <1%.
- Evolve has expanded to six Chicago-area SSAs and wards, including Wicker Park Bucktown #33, Old Town #48, and Albany Park #60.
- Company previously announced preliminary Q3 2026 revenue of ~$1.1M (record, +55% YoY, +40% sequential) in an 8-K filed Oct 15, 2026.
- No new financial data or earnings results are provided in this press release.
Financial Impact
No new financial figures; prior preliminary Q3 2026 revenue ~$1.1M (record high).
Risk Factors
- Pilot results may not replicate in other deployments or geographies.
- Company remains pre-profitable with negative EPS; cash burn and dilution risk persist.
- Municipal adoption cycles can be slow and subject to budget constraints.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3383388 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | SC 13D/A | $0.7700 | awaiting T+5 | — | $0.7974 (+3.56%) |
Oct 22, 2026 4d ago | 8-K | $0.7990 | awaiting T+5 | — | $0.7974 (+0.20%) |
Oct 22, 2026 4d ago | Press Release | $0.7990 | awaiting T+5 | — | $0.7974 (−0.20%) |
Oct 19, 2026 6d ago | SC 13D/A | $0.6893 | awaiting T+5 | — | $0.7974 (+15.68%) |
Oct 19, 2026 7d ago | Press Release | $0.7000 | awaiting T+5 | — | $0.7974 (+13.91%) |
Oct 15, 2026 11d ago | 8-K | $0.6992 $0.7990 | ▲ +14.27% | ▲ +15.29% | $0.7974 (+14.04%) |
Oct 15, 2026 11d ago | Press Release | $0.6992 $0.7990 | ▲ +14.27% | ▲ +15.29% | $0.7974 (+14.04%) |
Aug 3, 2026 12w ago | 8-K | $1.55 $1.27 | ▼ −18.06% | ▼ −20.09% | $0.7974 (−48.55%) |
Jun 9, 2026 19w ago | Insider Cluster | $1.72 $1.65 | ▼ −4.07% | ▼ −7.50% | $0.7974 (−53.64%) |
May 18, 2026 22w ago | Insider Cluster | $1.53 $1.79 | ▲ +16.99% | ▲ +14.70% | $0.7974 (−47.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers